New Frontiers in Asymmetric Catalysis

·
· John Wiley & Sons
eBook
448
āļŦāļ™āđ‰āļē
āļ„āļ°āđāļ™āļ™āđāļĨāļ°āļĢāļĩāļ§āļīāļ§āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāļĒāļ·āļ™āļĒāļąāļ™ Â āļ”āļđāļ‚āđ‰āļ­āļĄāļđāļĨāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āđ€āļāļĩāđˆāļĒāļ§āļāļąāļš eBook āđ€āļĨāđˆāļĄāļ™āļĩāđ‰

A compilation of recent advances and applications in asymmetric catalysis

The field of asymmetric catalysis has grown rapidly and plays a key role in drug discovery and pharmaceuticals. New Frontiers in Asymmetric Catalysis gives readers a fundamental understanding of the concepts and applications of asymmetric catalysis reactions and discusses the latest developments and findings. With contributions from preeminent scientists in their respective fields, it covers:

* "Rational" ligand design, which is critically dependent on the reaction type (reduction, oxidation, and C-C bond formation)
* Recent findings on activation of C-H bonds, C-C bonds, and small molecules (C=O, HCN, RN=C, and CO2) and the latest developments on C-C bond reorganization, such as metathesis
* Advances in "chirally economical" non-linear phenomena, racemic catalysis, and autocatalysis
* Some of the recent discoveries that have led to a renaissance in the field of organocatalysis, including the development of chiral BrÃķnstead acids and Lewis acidic metals bearing the conjugate base of the BrÃķnstead acids as the ligands and the chiral bi-functional acid/base catalysts

The book ends with a thought-provoking perspective on the future of asymmetric catalysis that addresses both the challenges and the unlimited potential in this burgeoning field. This is an authoritative, up-to-date reference for organic chemists in academia, government, and industries, including pharmaceuticals, biotech, fine chemicals, polymers, and agriculture. It is also an excellent textbook for graduate students studying advanced organic chemistry or chemical synthesis.

āđ€āļāļĩāđˆāļĒāļ§āļāļąāļšāļœāļđāđ‰āđāļ•āđˆāļ‡

Koichi Mikami is Professor in the Department of Applied Chemistry at the Tokyo Institute of Technology.

Mark Lautens is AstraZeneca Professor of Organic Synthesis and Merck Frosst/NSERC Industrial Research Chair in the Davenport Laboratories at the University of Toronto.

āđƒāļŦāđ‰āļ„āļ°āđāļ™āļ™ eBook āļ™āļĩāđ‰

āđāļŠāļ”āļ‡āļ„āļ§āļēāļĄāđ€āļŦāđ‡āļ™āļ‚āļ­āļ‡āļ„āļļāļ“āđƒāļŦāđ‰āđ€āļĢāļēāļĢāļąāļšāļĢāļđāđ‰

āļ‚āđ‰āļ­āļĄāļđāļĨāđƒāļ™āļāļēāļĢāļ­āđˆāļēāļ™

āļŠāļĄāļēāļĢāđŒāļ—āđ‚āļŸāļ™āđāļĨāļ°āđāļ—āđ‡āļšāđ€āļĨāđ‡āļ•
āļ•āļīāļ”āļ•āļąāđ‰āļ‡āđāļ­āļ› Google Play Books āļŠāļģāļŦāļĢāļąāļš Android āđāļĨāļ° iPad/iPhone āđāļ­āļ›āļˆāļ°āļ‹āļīāļ‡āļ„āđŒāđ‚āļ”āļĒāļ­āļąāļ•āđ‚āļ™āļĄāļąāļ•āļīāļāļąāļšāļšāļąāļāļŠāļĩāļ‚āļ­āļ‡āļ„āļļāļ“ āđāļĨāļ°āļŠāđˆāļ§āļĒāđƒāļŦāđ‰āļ„āļļāļ“āļ­āđˆāļēāļ™āđāļšāļšāļ­āļ­āļ™āđ„āļĨāļ™āđŒāļŦāļĢāļ·āļ­āļ­āļ­āļŸāđ„āļĨāļ™āđŒāđ„āļ”āđ‰āļ—āļļāļāļ—āļĩāđˆ
āđāļĨāđ‡āļ›āļ—āđ‡āļ­āļ›āđāļĨāļ°āļ„āļ­āļĄāļžāļīāļ§āđ€āļ•āļ­āļĢāđŒ
āļ„āļļāļ“āļŸāļąāļ‡āļŦāļ™āļąāļ‡āļŠāļ·āļ­āđ€āļŠāļĩāļĒāļ‡āļ—āļĩāđˆāļ‹āļ·āđ‰āļ­āļˆāļēāļ Google Play āđ‚āļ”āļĒāđƒāļŠāđ‰āđ€āļ§āđ‡āļšāđ€āļšāļĢāļēāļ§āđŒāđ€āļ‹āļ­āļĢāđŒāđƒāļ™āļ„āļ­āļĄāļžāļīāļ§āđ€āļ•āļ­āļĢāđŒāđ„āļ”āđ‰
eReader āđāļĨāļ°āļ­āļļāļ›āļāļĢāļ“āđŒāļ­āļ·āđˆāļ™āđ†
āļŦāļēāļāļ•āđ‰āļ­āļ‡āļāļēāļĢāļ­āđˆāļēāļ™āļšāļ™āļ­āļļāļ›āļāļĢāļ“āđŒ e-ink āđ€āļŠāđˆāļ™ Kobo eReader āļ„āļļāļ“āļˆāļ°āļ•āđ‰āļ­āļ‡āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļĨāļ°āđ‚āļ­āļ™āđ„āļŸāļĨāđŒāđ„āļ›āļĒāļąāļ‡āļ­āļļāļ›āļāļĢāļ“āđŒāļ‚āļ­āļ‡āļ„āļļāļ“ āđ‚āļ›āļĢāļ”āļ—āļģāļ•āļēāļĄāļ§āļīāļ˜āļĩāļāļēāļĢāļ­āļĒāđˆāļēāļ‡āļĨāļ°āđ€āļ­āļĩāļĒāļ”āđƒāļ™āļĻāļđāļ™āļĒāđŒāļŠāđˆāļ§āļĒāđ€āļŦāļĨāļ·āļ­āđ€āļžāļ·āđˆāļ­āđ‚āļ­āļ™āđ„āļŸāļĨāđŒāđ„āļ›āļĒāļąāļ‡ eReader āļ—āļĩāđˆāļĢāļ­āļ‡āļĢāļąāļš